Literature DB >> 7715375

Distortion product emission features and the prediction of pure tone thresholds.

B P Kimberley1.   

Abstract

Distortion product emission (DPE) growth functions, demographic data, and pure tone thresholds (PTTs) were recorded in 229 normal-hearing and hearing-impaired ears. Half of the data set (115 ears) was used by a discriminant analysis routine to classify DPE and demographic features into either a normal PTT group or an impaired PTT group (PTT greater than 30 dB SPL [sound pressure level]) at six frequencies in the audiometric range. The six discriminant functions developed from this classification process were then used to predict PTT group membership in the remaining 114-ear data set. Frequency-specific prediction accuracy was approximately 85% overall. Of the 45 DPE and demographic variables evaluated, the DPE amplitude associated with an f2 (a primary tone of frequency) of moderate level (50 dB SPL) and a frequency corresponding to PTT was generally most predictive. DPE features associated with frequencies immediately adjacent to the PTT frequency also appear to be useful. DPE level was found to be weakly correlated with subject age; perhaps for this reason, age was frequently included in discriminant functions. This study describes the DPE measures that can most reliably categorize PTTs as normal or impaired in large populations with varied cochlear hearing status.

Entities:  

Mesh:

Year:  1995        PMID: 7715375     DOI: 10.1288/00005537-199504000-00001

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

1.  Reliability of distortion-product otoacoustic emissions in the common marmoset (Callithrix jacchus).

Authors:  Michelle D Valero; Rama Ratnam
Journal:  Hear Res       Date:  2011-07-27       Impact factor: 3.208

2.  Use of distortion-product otoacoustic emissions for auditory evaluation in Menière's disease.

Authors:  N Pérez; J M Espinosa; S Fernández; R García-Tapia
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 3.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.